Fresenius SE & Co. KGaA (ETR:FRE)
40.79
+0.47 (1.17%)
Apr 28, 2026, 5:35 PM CET
Fresenius SE & Co. KGaA Employees
As of December 31, 2025, Fresenius SE & Co. KGaA had 178,583 total employees, including 131,789 full-time and 46,794 part-time employees. The number of employees decreased by 1,301 or -0.72% compared to the previous year.
Employees
178,583
Change (1Y)
-1,301
Growth (1Y)
-0.72%
Revenue / Employee
€147,391
Profits / Employee
€8,145
Market Cap
22.97B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 178,583 | -1,301 | -0.72% |
| Dec 31, 2024 | 179,884 | -13,981 | -7.21% |
| Dec 31, 2023 | 193,865 | -123,055 | -38.83% |
| Dec 31, 2022 | 316,920 | 842 | 0.27% |
| Dec 31, 2021 | 316,078 | 4,809 | 1.54% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,077 |
| Siemens Healthineers AG | 73,800 |
| Bayer Aktiengesellschaft | 87,280 |
| Sartorius Aktiengesellschaft | 14,042 |
| Fresenius Medical Care AG | 109,698 |
| Ottobock SE & Co. KGaA | 10,365 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,784 |
Fresenius SE & Co. KGaA News
- 20 days ago - EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 22.05.2026 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution - Wallstreet:Online
- 27 days ago - EQS-DD: Fresenius SE & Co. KGaA: Pierluigi Antonelli, buy - Wallstreet:Online
- 27 days ago - EQS-DD: Fresenius SE & Co. KGaA: Robert Möller, buy - Wallstreet:Online
- 1 year ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters
- 1 year ago - Fresenius SE Raises Guidance After Strong Kabi, Helios Performances - WSJ
- 2 years ago - Healthcare group Fresenius tops Q4 operating profit expectations - Reuters
- 2 years ago - Fresenius to assess whether state aid impacts bonus, dividend payouts - Reuters
- 3 years ago - Fresenius launches biosimilar version of AbbVie's Humira at 5% discount - Reuters